# Post Marketing Surveillance (PMS) Study for Velaglucerase Alfa (VPRIV) in India

> **NCT04429984** · — · COMPLETED · sponsor: **Shire** · enrollment: 21 (actual)

## Conditions studied

- Gaucher Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04429984
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-28
- **Primary completion:** 2023-04-22
- **Final completion:** 2023-04-22
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2023-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04429984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04429984, "Post Marketing Surveillance (PMS) Study for Velaglucerase Alfa (VPRIV) in India". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04429984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*